| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 27, 2025 | Jan 29, 2025 | Processa Pharmaceuticals, Inc. | CEO | Buy | 95.0 | +87,200 | 436.00% | ✗ | $69.5K |
| Jan 30, 2024 | Jan 31, 2024 | Processa Pharmaceuticals, Inc. | CEO | Buy | 91.3 | +10,000 | 100.00% | ✗ | $27K |